Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
27
Warrant Exposure
40
Convertible Debt
85
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 48%
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 65% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
model 55%
• Critical: only 0.4 months cash remaining
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (66/100)
Market Data
Market Cap$245.2K
Shares Outstanding1.61B
Float1.23B
Cash$9.5K
Debt$120.0K
Short InterestN/A
Institutional Holdings
6.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest1.44M
Days to Cover1.0
% of Float0.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2026-05-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual CNBX Dilution Snapshot
CNBX Pharmaceuticals Inc. (CNBX) has a DilutionScore of 66/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CNBX: xbrl on 2026-05-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: